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Chlamydia trachomatis from Australian Aboriginal
people with trachoma are polyphyletic composed
of multiple distinctive lineages
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Lesley T. Cutcliffe5, Fiona P. Douglas1, L. Valerie Asche1, John D. Mathews1,6, Susan I. Hutton1, Derek S. Sarovich1,
Steven Y.C. Tong1, Ian N. Clarke5, Nicholas R. Thomson2,7,* & Philip M. Giffard1,8,*
Chlamydia trachomatis causes sexually transmitted infections and the blinding disease
trachoma. Current data on C. trachomatis phylogeny show that there is only a single
trachoma-causing clade, which is distinct from the lineages causing urogenital tract (UGT)
and lymphogranuloma venerum diseases. Here we report the whole-genome sequences of
ocular C. trachomatis isolates obtained from young children with clinical signs of trachoma in a
trachoma endemic region of northern Australia. The isolates form two lineages that fall
outside the classical trachoma lineage, instead being placed within UGT clades of the
C. trachomatis phylogenetic tree. The Australian trachoma isolates appear to be recombinants
with UGT C. trachomatis genome backbones, in which loci that encode immunodominant
surface proteins (ompA and pmpEFGH) have been replaced by those characteristic of classical
ocular isolates. This suggests that ocular tropism and association with trachoma are
functionally associated with some sequence variants of ompA and pmpEFGH.
DOI: 10.1038/ncomms10688 OPEN
1 Global and Tropical Health Division, Menzies School of Health Research, Charles Darwin University, Darwin, Casuarina, Northern Territory 0811, Australia.
2 Pathogen Variation Programme, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge CB10 1SA, UK. 3 Functional Genomics
Centre Zu¨rich, University of Zurich, Zurich CH-8057, Switzerland. 4 Institute for Veterinary Pathology, Vetsuisse Faculty, University of Zurich, Zurich CH-
8057, Switzerland. 5 Department of Clinical and Experimental Science, Molecular Microbiology Group, University Medical School, Southampton General
Hospital, Southampton SO16 6YD, UK. 6 School of Population and Global Health, University of Melbourne, Melbourne, Victoria 3010, Australia. 7 Department
of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK. 8 School of Psychological and Clinical Sciences,
Charles Darwin University, Casuarina, Northern Territory 0811, Australia. * These authors contributed equally to this work. Correspondence and requests for
materials should be addressed to N.R.T. (email: nrt@sanger.ac.uk) or to P.M.G. (email: phil.giffard@menzies.edu.au).
NATURE COMMUNICATIONS | 7:10688 |DOI: 10.1038/ncomms10688 | www.nature.com/naturecommunications 1
T
he genus Chlamydia encompasses bacteria that are
obligate intracellular parasites with a distinctive life cycle.
Chlamydia trachomatis is a human-speciﬁc pathogen that
causes urogenital tract (UGT) and ocular infections1,2. Although
essentially all C. trachomatis strains can cause conjunctivitis,
trachoma is a chronic C. trachomatis ocular infection
characterized by rounds of reinfection, hypersensitivity
reactions with inﬂammation, conjunctival scarring and
entropion, ultimately leading to corneal scarring, which may
result in blindness3.
It is well established that strains of C. trachomatis differ as to
whether they are primarily associated with UGT infections or
trachoma. It has also long been known that different sequence
variants of the ompA gene, encoding a major outer membrane
protein, are markers for primary association with UGT infections
or trachoma4–7. OmpA genotypes A, B, Ba and C are associated
with trachoma, genotypes D-K associated with non-invasive UGT
infections, and genotypes L1-L3 and L2b associated with invasive
infections and lymphogranuloma venerum (LGV). Recent whole-
genome sequence-based studies have shown that although
recombination events mean that ompA sequence is not a
reliable phylogenetic marker across the species, isolates with
ompA sequences that deﬁne the trachoma ompA genotypes all fall
within a single clade of the C. trachomatis phylogenetic tree that
shares a distant common ancestor with one of the two UGT
lineages8–10. This ‘classical ocular’ lineage does not include UGT
or LGV ompA genotype isolates. The simplest interpretation of
these ﬁndings is that ocular tropism is a derived state that has
evolved only once and is deﬁned by the tropism-conferring
genomic variation speciﬁc to the branch leading to this lineage.
Ocular tropism in this context refers to association of particular
C. trachomatis strains with both: isolation from the eye and
clinical signs of trachoma. Although candidate functional markers
of tropism have been reported (reviewed in refs 11–13), the
problem inherent to such studies is differentiating functionally
signiﬁcant variation from natural segregation of polymorphisms
that have arisen through genetic drift and are therefore
association markers of the classical ocular lineage. In addition,
there are a small number of reports of trachoma associated with
strains with UGT ompA genotypes14–17.
Australia is the only developed country where trachoma
remains endemic, as well as being one of the few disease foci
outside Africa where trachoma has been studied in detail3. In
Australia, trachoma is exclusively associated with the Aboriginal
population of remote regions18.
Here we report the ﬁrst genome sequences of C. trachomatis
isolates taken from ocular swabs of Australian patients with
clinical trachoma. The isolates originate from a study of
ocular C. trachomatis in Aboriginal children and UGT
C. trachomatis in their mothers (termed the Mother–Child
study), conducted in the north of the Australian Northern
Territory (NT) between 1985 and 1993 (ref. 19). The study sites
were remote Aboriginal communities where the regional
trachoma prevalence was 12–28% in 0- to 14-year olds20, which
fulﬁlls the World Health Organization (WHO) deﬁnition (45%)
of trachoma endemicity. The study yielded cultured and stored
C. trachomatis isolates. Little genomic data exist for
C. trachomatis isolates causing trachoma from outside of
Africa. To more fully understand the natural history of
trachoma in Australia, and determine if it differs from other
parts of the world, we performed genome sequencing on a
selection of isolates. On the basis of genome-wide orthologous
single-nucleotide polymorphisms (SNPs), the Australian isolates
are not descended from the most common ancestor of the
classical ocular clade, but rather are close relatives of urogenital
isolates. This impacts current models regarding C. trachomatis
evolutionary history and determinants of anatomical tropism as
well as having implication for our attempts to eradicate trachoma.
Results
Culturing of historical trachoma isolates. The 1985–1991
Mother–Child study encompassed serological methods to type
the collected isolates19. Results were largely consistent with
Table 1 | Isolate characteristics and associated clinical data.
Sample no Serovar* ompA genotypew Age (years)z Trachoma gradingy
Aus25 Ba Ba 6 Months F1 P0 C0
Aus28 B Ba 9 Months F0 P2 C0
Aus30 C C 15 Months F1 P2 C0
Aus33 C C 15 Months F0 P2 C0
Aus36 B B 9 Years F1 P2 C0
Aus2|| B B — —
Aus3|| B B — —
Aus4|| B B — —
Aus5|| B B — —
Aus8|| C C — —
Aus9|| C C — —
Aus10|| C C — —
Aus40z B B 18 Years —
Aus41z B B 20 Years —
Aus42z B B 32 Years —
Aus43z B B 24 Years —
Aus44z B B 25 Years —
Aus45z B B 24 Years —
The serovar shown was determined by microimmunoﬂuorescence test using monoclonal antibodies as part of the standard protocol in the original sampling study and provided as a reference for the
serovars determined in this study. Trachoma grading was carried out according to the modiﬁed WHO system of 1981 (FPC system)63. For seven isolates, no clinical data were available.
Samples Aus40-Aus45 were isolated from cervical samples.
*Serotyping determined using monoclonal antibodies as part of the original sampling study.
wompA genotype determined from whole-genome sequence data in the present study.
zAge of patient at time of sampling.
yF¼ follicles, P¼ papillae, C¼ conjunctival scarring; all following a three graded scale.
||For these samples, no clinical data were available.
zThese samples were isolated from an urogenital site.
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expected associations between serovar and anatomical site of
isolation (Supplementary Table 1). The presence of serovar B
isolates in a signiﬁcant proportion of urogenital samples was
notable but not unprecedented, as there have been sporadic
reports of the isolation of serotype or genotype B strains in
urogenital specimens21–30. With growing knowledge of the
genome diversity of C. trachomatis and the understanding that
exchange of the ompA gene by recombination8–10,31–38 can mask
our appreciation of that diversity; in 2013 we successfully revived,
cultured and genome sequenced 12 ocular isolates from the
Mother–Child study. Five of the revived isolates were fully
documented and derived from research participants aged between
6 months and 9 years who displayed the follicles and/or papillae
consistent with trachoma at the time of sample collection
(Table 1). A further seven cultured samples could not be
directly linked to individual participants, but were isolates taken
from ocular swabs during that study. With the exception of one
ompA genotype Ba isolate, which had been previously miscalled
as serovar B, all ompA sequences reconstructed from our
data were consistent with the serovar data derived from the
Mother–Child study (Table 1).
Whole-genome phylogeny shows novel trachoma lineages.
The relationship of the sequenced isolates to a set of isolates,
representative of the C. trachomatis global diversity, was
determined using genome-wide orthologous SNPs8 (Fig. 1).
To preserve the phylogenetic signal putative recombined regions
were excluded from the analysis, as previously described39.
However, with or without these regions, the trees shared
essentially identical topologies (Supplementary Fig. 1a),
indicating that the branching order is not affected by removal
of recombined regions. The phylogenetic position of plasmids in
the isolates was concordant with the chromosomal phylogeny
(Supplementary Fig. 1b,c).
Surprisingly, the Australian isolates formed two separate
lineages (which we have denoted Oc2 and Oc3), both falling
outside the single classical lineage previously associated with
trachoma (here termed Oc1; Fig. 1). Oc2 and Oc3 are unique,
distinct and nested deeply within lineages that were previously
occupied exclusively by urogenital C. trachomatis isolates
(genotypes D–K; Fig. 1). Considering these Australian ocular
isolates carry ompA genes that are characteristic of the classical
ocular lineage and since it is well established that recombination
occurs in C. trachomatis8–10,32,34,36,40, we used a sliding window-
based approach to elucidate recombination events unique to the
ancestry of our isolates. Using this approach, all the Australian
ocular isolate genomes were compared against a set of published
reference C. trachomatis genomes encompassing all three biovars.
As expected from their position in the whole-genome species
phylogeny, the chromosome of Oc2 clade isolates share extensive
similarity to the D/UW-3 and G/11222 urogenital reference
genomes, whereas the Oc3 clade isolates are most similar to the
E/11023, F/SW4 and D/SotonD1 urogenital reference genomes.
OmpA recombination boundaries. Looking more closely at the
ompA genes from these isolates it was evident that ompA from the
ﬁve Australian genotype B strains (within Oc2) is itself a chimeric
sequence, in which the 50 end of the gene is identical to that of the
ompA from H/R31975 and highly similar to ompA genes from
other genotypes occupying closely branching positions on the tree
(Fig. 2). The remainder of the Australian genotype B ompA gene
is composed of a sequence that only differs from the ompA gene
of B/HAR36 at one base position (Fig. 2 and Table 2). The
boundaries for the recombined fragment including ompA in
the Oc3 genotype C isolates correspond closely to the ends of the
protein-coding sequence, whereas the fragment in the genotype
Ba isolates extends on either side of ompA over a 11,405–
16,142 bp region encompassing genes orthologous to ORFs pkn5
to JALI_6881 in the B/Jali20 genome (Genbank accession number
NC012686; Figs 2,3).
PmpEFGH genes are related to ocular orthologues. In addition
to ompA, the only locus in the Australian trachoma isolates we
could identify as being speciﬁcally similar to orthologues in the
classical trachoma lineage was pmpEFGH. This cluster encodes
polymorphic membrane proteins; associated with virulence41,42.
The Oc3 pmpE, pmpF, pmpG and pmpH sequences were all more
closely related to orthologues in the classical ocular lineage than
in any known urogenital isolates (Figs 4,5 and Supplementary
Fig. 2a–c). However, it is notable that the Oc3 Pmp sequences are
signiﬁcantly diverged from any previously reported sequences,
with 13, 11 and 3 unique amino-acid changes in PmpE, PmpF
and PmpH, respectively. The amino-acid alignments are shown
in Supplementary Fig. 3a–d.
Attempts to infer recombination events that have given rise to
the Oc3 pmpEFGH locus yielded a complex picture, with evidence
of mosaic structure both within the coding sequences and in
ﬂanking regions. For example, a 156 amino-acid stretch of PmpF
is identical to PmpF from UGT isolates (Supplementary Fig. 3b).
Also, the ﬂanking regions for the genotype Ba and genotype C
isolates in Oc3 differ, indicating that different recombination
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Figure 1 | C. trachomatis chromosomal phylogeny. Maximum likelihood
reconstruction of the phylogeny of C. trachomatis chromosomal sequences
using orthologous SNPs, with inferred recombined regions removed. The ompA
genotypes are included as the ﬁrst letters in the designations of the isolates.
The scale bar denotes number of SNPs. The established biovar-clusters are
indicated on the right; with an ocular, a lymphogranuloma venerum (LGV) and
two urogenital (UGT) clusters. The ocular clades are colour coded: Oc1
‘classical ocular lineage’ in red, Oc2 ompA genotype B Australian lineage in
purple, Oc3 ompA genotype Ba Australian lineage in blue and Oc3 ompA
genotype C Australian lineage in green. The novel ocular clades, Oc2 and Oc3
lie in clades that traditionally exclusively contain UGT strains.
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events have occurred in this region that nevertheless have yielded
identical pmpEFGH loci (Supplementary Fig. 4).
Genome-wide association study (GWAS) of the ocular phenotype.
We used the orthologous SNP data in a GWAS, to assess whether
there were other regions of the genome associated with trachoma
that had not been identiﬁed by the sliding window approach. As
expected, the ompA and pmpEFGH regions showed the strongest
associations (Fig. 6). The large number of SNPs with a Bonferroni
corrected  log10(P) 8.26 represent alleles that are associated with
trachoma, but which are found only in the classical trachoma
lineage and not in the Australian trachoma isolates. We reasoned
that these are all linked due to common descent in a largely clonal
lineage, and are unlikely to be functionally signiﬁcant. It was
concluded that the GWAS analysis provided no evidence for the
functional involvement in trachoma of any loci apart from ompA
and pmpEFGH.
Other putative tropism loci. Allelic variation in the tarP gene,
which encodes a type III secreted effector protein, has been
proposed to correlate with C. trachomatis anatomical tropism
when comparing African trachoma isolates with other pathovars
of C. trachomatis43,44. However, this is not true of the tarP genes
in our ocular isolates, which are consistent with those of the
urogenital lineages they clustered within the genome-wide
phylogeny. Notably, the only previous study44 of Australian
trachoma-associated C. trachomatis, which included the sequence
of a gene other than ompA, also found that tarP alleles in the
Australian ocular genotype isolates did not cluster with tarP
alleles from African trachoma isolates. Comparison of these tarP
and ompA alleles with those found in our isolates showed
identical ompA and tarP allele combinations.
Truncating mutations in the tryptophan synthesis genes (trp
operon) have received considerable attention as characteristic
markers of ocular tropism23. The trp operon in Oc2 is identical to
that found in several common urogenital C. trachomatis isolates,
for example, G/11222, F/SW4 and E/11023. Similarly, the trp
operon in Oc3 is identical to that in the urogenital isolate F/70.
There is no evidence for variations that would truncate the gene
products.
Urogenital and ocular serovar B form one lineage. It was of
interest that genotype B strains were isolated in signiﬁcant
numbers from both the ocular and UGT sites in the Mother–
Child study. In contrast, genotype Ba and C isolates were not
obtained from the UGT site (see Methods for details). To
investigate this further, six serovar B UGT isolates from the
Mother–Child study were propagated and genome sequenced.
The sequences were nearly identical to the Oc2 genotype B iso-
lates, and there was no indication that the ocular and UGT iso-
lates formed different group (Supplementary Fig. 5). This
indicates that Oc2 was a lineage causing trachoma and being
extensively transmitted sexually in the study area, at the time of
sample collection.
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Figure 2 | SNP patterns of the ompA gene in Oc2 and Oc3 genotype C isolates. SNP patterns in the region surrounding the ompA gene showing evidence
for sharing of alleles between the Oc1 clade and the Oc2 or Oc3 lineages. The B/Jali20 genome (Genbank accession number NC012686) was used as the
comparator genome. Genes are shown as blue boxes along the top with direction of transcription indicated by arrow heads, based on the B/Jali20 genome
annotation. To the left, the chromosomal phylogeny (as in Fig. 1) indicates which genome is being compared with the B/Jali20 genome. Each horizontal line
indicates a position where there is a SNP that separates the relevant genome sequence from the B/Jali20 genome sequence. The Oc2 clade has an ompA
gene sequence most similar to the B/Har36 (indicated by red boxes), with the exception of the start of the gene, which is most similar to the two genotype
H strains (indicated by the green boxes). The Oc3 ompA genotype C isolates have an ompA sequence most similar to that in the C/TW3 (blue boxes).
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Discussion
This work presents the ﬁrst genome sequencing of trachoma-
associated C. trachomatis isolates from Australia. The isolates,
which possess ocular-associated ompA variants, are from patients
in trachoma-endemic regions presenting with a pathology and
epidemiology typical of trachoma.
Given that previous species-wide multilocus sequence typing
and genome sequence-based studies of C. trachomatis have
consistently shown that isolates with ocular-associated ompA
types fall within a single, monophyletic evolutionary lineage8–10,
it was expected that the Australian trachoma isolates would also
occupy a position within this classical ocular clade. However,
phylogenetic reconstruction based on whole-genome SNPs show
our isolates form two distinct lineages, each nested deeply within
clades of global urogenital isolates and separated from the
classical ocular lineage. The phylogenetic position of the plasmids
in the Oc2 and Oc3 lineages is consistent with the whole-genome
phylogeny, providing additional credibility regarding their
evolutionary history. Previous studies have demonstrated
concordance of chromosome and plasmid phylogenies8,45,
although the Ba/Apache2 strains, which carries a plasmid
identical to those found in urogenital strains (F/SW4, F/SW5/
D/SotonD1 and F/SotonF3) is an exception.
Our observations challenge the model suggested by previous
studies that ocular tropism arose only once. The discovery that
some Australian trachoma C. trachomatis genomes are almost
entirely ‘urogenital’ apart from the ompA gene suggests that the
evolution of the ocular ompA alleles was functionally signiﬁcant
to the adaptation to the ocular niche and ability to cause
trachoma. Remarkably, however, phylogenetic reconstruction has
shown that the ‘ocular’ ompA alleles themselves do not have a
single origin28,46. Speciﬁcally, ocular ompA variants A and C
deﬁne a group within the ompA sequence diversity that also
includes the urogenital H, Ia, J and K alleles. In contrast, ompA
alleles B and Ba are unrelated to A and C, but are related to E
alleles (Supplementary Fig. 6). It is not possible to accommodate
the triad of a single origin of ocular strains, a central role for
ompA in conferring tropism, and the polyphyletic nature of
ocular ompA alleles into an internally consistent model. The
simplest interpretation and our new model for adaption to the
trachoma biovar phenotype is that the ancestral virulence
property of non-LGV C. trachomatis is essentially identical to
current non-LGV UGT strains of C. trachomatis, in that they
could cause urogenital infections and conjunctivitis. However,
environmental conditions favouring long-term ocular infection
lead to the parallel evolution of multiple ompA and pmpEFGH
variants, which aid adaptation to that niche. These ‘ocular’ alleles
were added to the recombining gene pool and shared between
strains through horizontal gene transfer. Thus, when
environmental/social conditions favour the emergence of
trachoma, the strains that have acquired these ‘ocular’ alleles
will be at a selective advantage and rapidly emerge as ‘trachoma’
strains. Such a model has many parallels in bacterial evolution,
particularly in antibiotic resistance. For example, the use of
third-generation cephalosporins selects both the de novo
appearance of point mutations that confer extended spectrum
activity on b-lactamases, and also the radiation of lineages that
have acquired the mutated genes from a recombining gene pool47.
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Figure 3 | SNP patterns of the ompA gene in Oc3 genotype Ba isolates. SNP patterns in the region surrounding the ompA gene showing evidence for
sharing of alleles between the Oc1 clade and the Oc2 or Oc3 lineages. The B/Jali20 genome (Genbank accession number NC012686) was used as the
comparator genome. Genes are shown as blue boxes along the top with direction of transcription indicated by arrow heads, based on the B/Jali20 genome
annotation. To the left, the chromosomal phylogeny (as in Fig. 1) indicates which genome is being compared with the B/Jali20 genome. Each horizontal line
indicates a position where there is a SNP that separates the relevant genome sequence from the B/Jali20 genome sequence. The genotype Ba isolates in
the Oc3 clade have a fragment including an ompA sequence that is most similar to the Ba/Apache2 strain (indicated by the red box).
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A corollary of this is that the apparent existence of the classical
ocular lineage is a consequence of geographical sampling bias. We
see no reason to assume that all trachoma-associated ompA alleles
ﬁrst arose in the classical ocular lineage.
It is important to note that there was strong evidence for
functional tropism in C. trachomatis strains arising from the
Mother–Child study. Although it is well known that UGT strains
of C. trachomatis can cause conjunctivitis, primarily in adults and
newborn infants, this does not have the characteristic clinical and
epidemiological pattern of trachoma48–50. The ocular isolates
analysed in this study are from a known trachoma endemic area,
from young but not infant children exhibiting typical trachoma
signs. Furthermore, we demonstrated a statistically signiﬁcant
association between serovar/strain and anatomical site of
isolation (see Methods for details). We are therefore conﬁdent
that our ocular isolates cannot be classed as urogenital strains
causing conjunctivitis.
The identiﬁcation of multiple lineages associated with ocular
tropism will facilitate identiﬁcation of functional markers of
tropism that have previously been impossible to differentiate
from drift. A search for loci in the Australian trachoma-
associated C. trachomatis isolates with high similarity to those
in the classical ocular lineage yielded only one hit apart from the
ompA, the pmpEFGH loci in Oc3; and this was conﬁrmed by the
GWAS analysis.
The exact functions of the pmp genes remain to be determined,
but certain protein features have been suggested to be of
importance for pathogen–host interaction33,35,51–53, such as the
clustering and conservation of tetrapeptide motifs, GGA(I,L,V)
and FxxN in the N-termini. The Pmp variants in the Oc3 lineage
display novel amino-acid changes and are evidently from a
yet-unsampled horizontal gene transfer donor. However, only
PmpE aa303 and PmpF aa385 affect GGA(I,L,V)/FxxN motifs
(Supplementary Fig. 3a,b). These variants create new FxxN motifs
that overlap with existing motifs, so the functional consequence is
likely limited. Of more signiﬁcance may be the presence of two
motifs uniquely shared by the Oc1 and Oc3 lineages (PmpF
FxxN aa384-7 and PmpH GAA(I,L,V) aa303-6, Supplementary
Fig. 3b,d). This may be worthy of further study.
Supporting evidence for the involvement of the pmpEFGH
genes in adaptation to the trachoma biovar phenotype can be
seen in the genetic make-up of the unusual C. trachomatis isolate
TW-448. TW-448 is a variant of the urogenital ompA genotype D
termed genotype Da54. It was isolated from a trachoma case in an
endemic trachoma region in Southern Taiwan, and is from a
small collection of similarly anomalous isolates from a single
Taiwanese family15. On the basis of a partial genome sequence,
TW-448 has a predominantly ‘urogenital’ genome, but the
pmpEFGH locus has the appearance of being derived from
the classical ocular lineage34,35 This locus is identical to the
orthologue in isolate TW-3, which is an ompA genotype C
trachoma isolate from Taiwan. This suggests recent horizontal
gene transfer of pmpEFGH from the classical ocular lineage to a
urogenital TW-448 precursor, and it was suggested by Gomes and
co-workers that this locus may have a role in tropism34. Oc2, Oc3
and TW-448 therefore constitute three trachoma-associated
lineages that, on the basis of genome-wide phylogeny are not
located within the classical ocular lineage. The Oc2 lineage has
acquired an ‘ocular’ genotype B ompA gene, isolate TW-448 has
acquired ocular pmpEFGH loci and the Oc3 lineage has acquired
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Figure 4 | SNP patterns of pmpEFGH loci. SNP patterns in the region including the pmpE, pmpF, pmpG, pmpH genes showing evidence for sharing of alleles
between the Oc1 clade and the Oc2 or Oc3 lineages. The B/Jali20 genome (Genbank accession number NC012686) was used as the comparator genome.
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left, the chromosomal phylogeny (as in Fig. 1) indicates which genome is being compared with the B/Jali20 genome. Each horizontal line indicates a
position where there is a SNP that separates the relevant genome sequence from the B/Jali20 genome sequence. The sequence of the isolates in the Oc3
clade show the highest similarity to the Oc1 clade, with the most striking resemblance observed for the pmpH gene.
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ocular-like pmpEFGH loci, and two different ocular ompA genes
(genotype Ba and genotype C) in independent events. Therefore,
sampling to date has revealed three independent ompA
recombination events, and two independent pmpEFGH
recombination events associated with evolving towards the
trachoma biovar phenotype. Furthermore, a search of the
literature and databases yielded no results describing horizontal
transfer of other loci contributing to the adaptation to the
trachoma biovar phenotype. Collectively, these observations
constitute compelling evidence that particular sequence variants
of the major surface proteins OmpA, and the Pmp family
members are critical to the trachoma biovar phenotype. This is
biologically plausible, as major surface proteins can mediate both
interactions with the host, and also confer physical properties on
the elementary bodies that could be connected with survival. It is
intriguing that the Oc2 genotype B isolates are similar to the
classical ocular lineage at ompA but not pmpEFGH. On the basis
of anatomical distribution in the Mother–Child samples, and
the virtually identical genomes of the ocular and UGT
representatives, these have an intermediate tropism that allows
both association with clinically typical trachoma and also
extensive sexual transmission. We cannot rule out that other
loci can contribute to tropism, but our study has given no
indication as to the existence or nature of such loci.
A substantial body of evidence that truncating mutations in the
trp operon are functional markers of ocular tropism has been
accumulated23. Although our results do not provide additional
evidence to support this model, a role for trp operon decay in
adaptation to the ocular niche certainly cannot be ruled out.
Decay of this operon may be a parallel evolutionary phenomenon
that can occur in trachoma-associated lineages. Although this
may contribute to adaptation, our evidence indicates it is not the
sole determinant of tropism, and that adaption to the ocular niche
can involve subsets of functional markers of adaptation.
The unexpected results of this study raise the question
of whether the Oc2 and Oc3 lineages are representative of
widespread trachoma strains in Australia. Several strands of
evidence indicate that, in the case of Oc3 isolates, they are. First,
the isolates in this study were from ocular swabs from young
children with signs of trachoma, and thus represent what is
typically seen in trachoma endemic areas. Second, there was a
highly signiﬁcant association between ompA genotype and
anatomical site of isolation (see Methods for details), with
trachoma cases in the Mother–Child study exclusively displaying
classical trachoma ompA serotypes. Third, the ompA sequences
from our ompA genotype Ba and C isolates are identical to
the most prevalent ompA sequences previously described in
Australian ompA genotype Ba and C trachoma isolates49,55.
Finally, the ﬁndings of Lutter and co-workers concerning the tarP
sequences44 are strongly indicative that our isolates are closely
related to other reported Australian ocular isolates.
Table 2 | Variations in the ompA gene.
ompA
genotype (n)
Closest match Nucleotide
change
Amino-acid
change
B (5) B/Har36
(this study)
C129T* Synonymous
A154G* Thr 52 Ala
A184G* Met 62 Val
G186T* Met 62 Val
T195C* Synonymous
T198A* Synonymous
A228T* Synonymous
C246T* Synonymous
A249G* Synonymous
G586A Val 196 Ile
Ba (2) Ba/Apache2
(AF063194)
A511Gw Ser 171 Gly
C662Tw Pro 221 Leu
C (5) C/TW3
(AF352789)
T569Cw Ile 190 Thr
A571Gw Asn 191 Asp
G972Aw Synonymous
G1003Tw Ala 335 Ser
A1063Cw Met 356 Leu
The trachoma-associated strains from Australia were compared with closest reference strains.
*These SNP changes in the ompA genotype B isolates correspond exactly with the sequence of a
serovar H strain, and is likely the result of a recombination event creating a chimeric ompA
sequence.
wThese variations have been observed previously in trachoma patients in Australia.
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Figure 5 | PmpH amino acid phylogeny. Maximum likelihood-inferred
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Oc1.
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Previous studies of ocular isolates from Australia have not
described ompA genotype B isolates, so the distribution of the
ompA genotype B Oc2 lineage remains unknown. Chimeric ompA
sequences identical to the variants in the Oc2 isolates from this
study (Table 2) have been previously been described in ompA
genotype B urogenital isolates from outside of Australia23,24,28.
Our study yielded no classic trachoma lineage Oc1 genomes,
reinforcing the model that the extensive signs of trachoma seen in
this endemic region are attributable to a non-classical set of
chlamydial ocular lineages.
In light of the theory that C. trachomatis may have been
associated with primates long before the emergence of modern
humans56, a possible explanation for the observed geographical
distribution of the Australian strain genotypes may be that they
represent strains that were carried with the ﬁrst wave of migration
out of Africa that populated Australia 70,000 years ago57, and
have since then remained relatively isolated within the Australian
Aboriginal population. However, given the close relationship of
Oc2 and Oc3 to known UGT lineages, the accumulating evidence
for frequent recombination by C. trachomatis, the known
extensive interaction of Australian Aboriginal people with other
human populations in historical times3,58, and the high
prevalence of ‘conventional’ UGT C. trachomatis strains in the
contemporary Australian Aboriginal population59,60; there is no
compelling evidence to support the notion that Oc2 and Oc3
represent early diverged lineages that were carried with the initial
migration of people to Australia. However, more deﬁnitive
information regarding the antiquity of Oc2 and Oc3 must await
analysis of more isolates from around the world, and better
understanding of the C. trachomatis molecular clock.
This study has public health implications. Trachoma remains
a health burden in Australia, despite initiatives directed at
elimination18,61. The WHO-deﬁned target of elimination
programmes is o5% prevalence62. Our results indicate that
presence of residual ocular strains provide potential for gene
variants assisting adaptation towards the trachoma biovar
phenotype to be transferred to prevalent and successful UGT
strains, and so facilitate trachoma persistence and
re-emergence. The evidence that this has happened multiple
times in Australia suggests that this is not a unique event. In
addition, the apparent ability of ompA genotype B lineages to
behave as either UGT or trachoma strains could also underpin re-
emergence. This provides additional justiﬁcation for reducing the
burden of all C. trachomatis infections, ocular and UGT, in
disadvantaged communities where trachoma re-emergence is
possible, as well as continuing to address the social conditions
that maintain trachoma endemicity.
Methods
Mother–Child study sampling. The sequenced isolates were derived from
research conducted in the north of the NT of Australia between 1985 and 1993.
The research project and interim results were described by authors L.V.A. and
S.I.H. in a published long-form conference abstract19. In brief, the research entailed
ocular sampling of children from Aboriginal communities in the dry ‘cattle
country’ of the NT, south-west of the town of Katherine; ocular sampling of
Aboriginal children from three Aboriginal communities on the coast of the NT;
cervical sampling of the mothers of the children from the coastal communities; and
cervical sampling of women from a Darwin gynecology clinic. In addition,
nasopharyngeal and rectal sites were sampled in some children. Essentially, all the
sampling was performed by author F.P.D., who also prepared clinical notes
associated with each sample. This included trachoma grading in accordance with
the modiﬁed WHO system of 1981 (FPC system)63.
For ocular sampling, the swabs used were sterile, cotton tipped and aluminium
shafted (Disposable Products Pty Ltd). Ocular swabs were taken from the upper
subtarsal conjunctiva, unless upper lid eversion was not possible, in which case the
lower subtarsal conjunctiva was swabbed after removal of any exudate. Each swab
was put into a glass or polypropylene vial containing 1ml sucrose phosphate
transport medium (buffered sucrose phosphate (0.4M) with 10% fetal calf serum,
100 mgml 1 streptomycin sulphate, 20 mgml 1 vancomycin hydrochloride and
2.5 mgml 1 amphotericin B). The swab shaft was trimmed with sterile scissors,
then the vial capped and stored at 4 C for transport to the laboratory, and storage
at  70 to –80 C.
Original cell culture and serotyping of C. trachomatis isolates. Isolates were
initially cultured in 5ml vials on McCoy cells64, by the method of Smeltzer et al.65
After storage at  70 C for between 2 weeks and 3 years, cultures were serially
passaged on McCoy cell monolayers in 5ml vials, with infectivity of the monolayer
being assessed after 72 h incubation using an inverted microscope. Passage, in
increasing volumes, was continued until infectivity either reached 40–80% or failed
to increase after at least ﬁve passages. The monolayer from the ﬁnal ﬂask was
divided into two portions: one was resuspended in 1ml growth medium and stored
at  70 C, and the other resuspended in 0.05ml PBS with 0.02% (v/v)) formalin
and stored at 4 C until used for serotyping.
All serotyping procedures were performed in late 1980s and early 1990s. The
isolates were serotyped by the micro-IF procedure of Wang et al.5, using the
‘Chlamydia trachomatis monoclonal antibody serotyping kit for all 18 serovars’
(Washington Research Foundation), largely in accordance with the manufacturer’s
instructions. Fluorescence from the ﬁnal reaction with sheep anti-mouse polyvalent
immunoglobulin conjugated with ﬂuorescein isothiocyanate (Silenus, ICI
Diagnostic Division), diluted 1:30 in PBS, was read using an epiﬂuorescence
microscope. Serotypes were determined by comparing the observed ﬂuorescence
patterns with prototype strain reactions, as speciﬁed by the kit manufacturer.
The outcomes of the sample collection, culturing and serotype determination
are shown in Supplementary Table 1. It can be seen that there was a signiﬁcant
correlation between anatomical site of isolation and serovar (Fisher’s Exact Test
and w2 P-value o10 7). These were calculated using a 2 2 contingency table
from the data in Supplementary Table 1, in which isolates were classed as being
‘ocular’ or ‘UGT’ serotypes, and sites of isolation either ‘ocular’ or ‘UGT’.
Regarding the potentially ambiguous data, ‘D/D0’ was classed as a urogenital
serotype, the rectum was classed as a UGT site of isolation, and the nasopharynx
was classed as an ocular site of isolation. Serotype C and Ba isolates were found
exclusively in non-UGT samples, whereas serovar B isolates displayed less
anatomical speciﬁcity, with 7 isolates being derived from cervical swabs as well as
43 from ocular swabs in trachoma endemic areas. Conversely, the UGT serotypes
were found predominantly in UGT samples.
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Figure 6 | Genome-wide association study of the ocular phenotype. Manhattan plot showing genome-wide association data comparing ocular strains
(Oc1, Oc2 and Oc3) against all other strains (UGTand LGV). Each red dot in the graph is a SNP. The x axis shows the genomic position and summary gene
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each SNP. Red arrows show the two regions of very strong association with the ocular phenotype, containing ompA and pmpEFGH, respectively.
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In 2012, we commenced an initiative to sequence the genomes of trachoma-
associated C. trachomatis from this study. All available hard copy material
associated with study activities in the 1980s to 1990s was extracted from the
Menzies School of Health Research archives and inspected. This yielded the
original hand-written clinical notes prepared by author F.P.D., as well as the
culturing and serotyping results (Supplementary Table 1).
We endeavoured to culture frozen isolates from ocular swabs. Isolates in the
form of frozen ‘antigen reserve’ cultures were physically located and their identities
conﬁrmed. This was performed primarily by authors P.A. and S.I.H. S.I.H.
performed the culturing and serotyping in the 1980s and 1990s, and curated the
culture collection, so there was considerable continuity of knowledge and expertise.
To minimize the probability of sequencing isolates associated with perinatal
conjunctivitis or adult follicular conjunctivitis, we conﬁned our search to isolates
from research participants between the ages of 6 months and 10 years. Seventeen
frozen cultures of isolates that met the above criteria were transported to the
laboratory of author I.N.C. Author P.A. attempted to culture all of these, to obtain
sufﬁcient genomic DNA for sequencing.
Recent cell culturing. Frozen isolates were revived and propagated in McCoy cell
(American Type Culture Collection) monolayers. The cells were grown in DMEM
supplemented with 10% fetal calf serum. The inocula were centrifuged onto the
conﬂuent monolayer at 750g for 30min at room temperature. Infected cultures
were grown in DMEM supplemented with 10% fetal calf serum
plus cyclohexamide at 1 mgml 1 and gentamicin at 20 mgml 1, for 72 h.
C. trachomatis inclusions were identiﬁed using a phase contrast microscope.
Isolates were propagated until high level of infection (80–100% of cells) was
achieved. Isolates were passaged through increasing volumes, starting in 96-well
plates, via 24-well and 6-well plates, to 25 cm2 tissue culture (T25) ﬂasks. At the
plate stages, isolates were cultured on individual plates to minimize risk of mix-ups
and contamination. In the ﬂask stage, each isolate was handled separately.
Infected monolayers were detached from ﬂasks using a cell scraper and
centrifuged at 3,000g for 10min. The infected cell pellet was resuspended in cold
10% PBS and homogenized using glass beads and vortexed at full speed for a
minute, to open cells and release EBs. Cell debris was removed by centrifugation at
250g for 5min, and the supernatant containing partially puriﬁed elementary bodies
was mixed with an equal volume of phosphate buffer containing 0.4M sucrose
(4SP), before storage at  80 C. Culturing was successful for ﬁve isolates: Aus25,
Aus28, Aus30, Aus33 and Aus36. Aus25 was recorded as ‘West Coast, serotype Ba’,
Aus28 and Aus36 as ‘West Coast, serotype B’, and Aus30 and Aus33 as ‘Tropical
Coast, serotype C’. These were unambiguously identiﬁed and matched with original
clinical notes.
In addition, another seven stored isolates were successfully cultured by author
H.M.B.S.S. These were frozen in T25 culture ﬂasks. These vessels had been
originally labelled only with serotype designations, and not with study-related
code-numbers. Therefore, although these isolates are certainly derived from the
study (no other C. trachomatis are stored at the Menzies School of Health
Research), they could not be matched to clinical or epidemiological data. These
isolates have been named Aus2, Aus3, Aus4, Aus5 (serotype B), and Aus8, Aus9
and Aus10 (serotype C). The possibility that these isolates overlap with isolates
Aus25, Aus28, Aus30, Aus33 and Aus36 cannot be ruled out. Although it is
unlikely, this possibility was taken into account in the interpretation of the results.
Six serovar B isolates from cervical samples (Aus40, Aus41, Aus42, Aus43,
Aus44 and Aus45) were revived and cultured as described above. These isolates
were used to provide context for the ocular serovar B isolates.
DNA extraction and sequencing. For each isolate, three T25 ﬂasks at 80–100%
infectivity were used for DNA extraction. DNA was extracted and puriﬁed using a
Promega Wizard Genome Puriﬁcation kit (Promega UK) according to the
manufacturer’s protocol. The quality of the DNA was assessed by agarose gel
electrophoresis. Isolates were sequenced using the Illumina HiSeq or MiSeq
platform. The protocol used either 100-base reads (Aus2, 3, 4, 5, 8, 9, 10) with
250–300 base inserts on the HiSeq platform, or 150-base reads (Aus25, 28, 30, 33,
36, 40–45) with 250–300 base inserts on the MiSeq platform. These samples were
among 96 samples multiplexed in one lane. The sequencing runs provided an
average of 6 million reads (658Mb) per isolate. The sequence read archive (SRA)
numbers and accession numbers for all strains used in this study are presented in
Supplementary Table 2.
Phylogenetic reconstruction. A whole-genome alignment from the work by
Harris et al.8 was used to create a consensus sequence in Ugene. For all samples, the
reads were mapped against the consensus sequence using SMALT, resulting in an
average genome coverage of 99.125% and average depth of coverage of 338x. For
samples where published sequences were used, synthetic reads were created in silico
from the whole-genome sequences (100 bp reads, with 300 bp insert, for each base
along the genome). SNPs were identiﬁed using a combination of samtools mpileup
and bcftools. Filters were applied so that only high-quality SNPs were accepted,
where sites were excluded if the SNP quality score was less than 30 or the SNP was
present in less than 75% of the reads66. A new alignment was created from the
mapping data and used for phylogenetic reconstruction using RAxML v7.0.4 under
a Generalized Time Reversible model of evolution with a g correction for among-
site rate variation with four rate categories. A previously described iterative
recombination removal method was applied to reduce the effect of recombination
on the phylogeny67. In the phylogeny, the three separate ocular clades were
designated: Oc1 (classical trachoma lineage), Oc2 (novel trachoma lineage
composed of Australian serovar B strains) and Oc3 (novel trachoma lineage
composed of Australian serovar Ba and C strains).
Horizontal gene transfer from Oc1 trachoma lineage. Sequence identity to a
known set of strains was interrogated using mapping. A set of 15 published full
genomes representative of the C. trachomatis diversity were chosen and aligned
with Mauve68 and manually error corrected, as previously described8. The query
sequence was mapped against an un-gapped version of this alignment using
SMALT (as above). A sliding window approach (defaults were: whole genome:
block size of 5,000 and 1,000 bp sliding window or, for genes: block size of 10 and a
5 bp sliding window) used mapping coverage as a proxy for similarity. The
mapping depths were overlaid using the alignment and a consensus ‘top match’
identiﬁed the largest contiguous segments with mapping depth 490% of the
maximum at each position. To identify regions that may have been derived from
the classical ocular lineage, we searched for regions in which classical ocular
reference genomes transitioned to being the most similar to the Oc2 or Oc3
isolates. Such regions were manually inspected to determine the number of SNPs
involved in conferring this aberrant relative similarity. Only regions of similarity in
which the signal for putative recombination was 45 SNPs per 1,000 bp window
were considered for further analysis. The regions identiﬁed in this scan were
further analysed in detail using the SNP barcode method described below.
SNP barcoding. For all samples, reads were mapped against the B_Jali20 reference
strain (NC012686) using the mapping protocol described above. The resulting SNP
matrix was used together with the phylogenetic tree described above, to generate
the ﬁgures of SNP barcodes with reference to B/Jali20.
Genome-wide association study. Short read data from all strains in Fig. 1 were
mapped against the B_Jali20 reference strain (NC012686) using SPANDx v2.6
(ref. 69), with default parameters. The resulting orthologous SNP matrix was used
as input for a microbial GWAS using PLINK70, with the phenotype of interest
being isolation from a trachoma case. Strains with an association with trachoma
(Oc1, Oc2 and Oc3) were treated as the group displaying the phenotype, and
compared against all other strains in the study. Bonferroni correction for multiple
testing was applied, with an adjusted  log10(P)-value threshold for signiﬁcance of
5.44. GWAS results were displayed using the Integrative Genome Viewer (IGV)
software (Broad Institute).
Ethics. Research from 1985 to 1993 was approved by the Institutional Ethics
Committee of the Menzies School of Health Research, and participants provided
informed consent. The Human Research Committee of the Northern Territory
Government Department of Health provided a letter indicating that the genome
sequencing did not require further ethical clearance.
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